Previously conducted in silico toxicogenomic analyses of CPF activity, obtained by Ingenuity Pathways Analyses (IPA), revealed a gene regulatory network potentially involved in thyroid carcinogenesis. This evidence concerns the gene NR5A2 and thyroid gland disorder.